Oric Pharmaceuticals Stock Last Dividend Paid

ORIC Stock  USD 9.90  0.07  0.70%   
Oric Pharmaceuticals fundamentals help investors to digest information that contributes to Oric Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Oric Stock. The fundamental analysis module provides a way to measure Oric Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oric Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Oric Pharmaceuticals Company Last Dividend Paid Analysis

Oric Pharmaceuticals' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Oric Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Oric Pharmaceuticals is extremely important. It helps to project a fair market value of Oric Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Oric Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Oric Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Oric Pharmaceuticals' interrelated accounts and indicators.
-0.870.520.950.910.030.970.93-0.310.95-0.770.930.960.87-0.990.79-0.65
-0.87-0.35-0.79-0.92-0.33-0.83-0.830.05-0.890.75-0.83-0.78-0.940.91-0.930.56
0.52-0.350.350.360.250.450.35-0.520.5-0.090.350.370.31-0.480.52-0.79
0.95-0.790.350.91-0.170.990.99-0.420.93-0.890.991.00.8-0.950.7-0.6
0.91-0.920.360.910.210.930.93-0.230.98-0.840.930.90.93-0.950.9-0.56
0.03-0.330.25-0.170.21-0.09-0.140.510.180.24-0.14-0.190.36-0.060.50.06
0.97-0.830.450.990.93-0.090.99-0.440.96-0.870.990.990.83-0.980.76-0.68
0.93-0.830.350.990.93-0.140.99-0.440.93-0.941.00.980.81-0.950.74-0.64
-0.310.05-0.52-0.42-0.230.51-0.44-0.44-0.320.39-0.44-0.41-0.020.3-0.160.78
0.95-0.890.50.930.980.180.960.93-0.32-0.790.930.920.9-0.970.88-0.64
-0.770.75-0.09-0.89-0.840.24-0.87-0.940.39-0.79-0.94-0.88-0.70.81-0.630.51
0.93-0.830.350.990.93-0.140.991.0-0.440.93-0.940.980.81-0.950.74-0.64
0.96-0.780.371.00.9-0.190.990.98-0.410.92-0.880.980.79-0.960.67-0.59
0.87-0.940.310.80.930.360.830.81-0.020.9-0.70.810.79-0.890.87-0.45
-0.990.91-0.48-0.95-0.95-0.06-0.98-0.950.3-0.970.81-0.95-0.96-0.89-0.830.65
0.79-0.930.520.70.90.50.760.74-0.160.88-0.630.740.670.87-0.83-0.65
-0.650.56-0.79-0.6-0.560.06-0.68-0.640.78-0.640.51-0.64-0.59-0.450.65-0.65
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

Oric Dividend Paid And Capex Coverage Ratio

Dividend Paid And Capex Coverage Ratio

(105.97)

At present, Oric Pharmaceuticals' Dividend Paid And Capex Coverage Ratio is projected to decrease significantly based on the last few years of reporting.
Based on the recorded statements, Oric Pharmaceuticals has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Oric Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Oric Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Oric Pharmaceuticals' managers, analysts, and investors.
Environmental
Governance
Social

Oric Fundamentals

About Oric Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Oric Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Oric Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticals Stock:
Check out Oric Pharmaceuticals Piotroski F Score and Oric Pharmaceuticals Altman Z Score analysis.
For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Return On Assets
(0.29)
Return On Equity
(0.46)
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.